Fundraising FoxAstute Medical
San Diego, US · Delaware corporation · 3 known investors
Find your way into Astute Medical
Sign up to see every warm intro you have to Astute Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Astute Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
bioMérieux develops in vitro diagnostic systems and molecular testing panels for pathogen detection in clinical, food safety, and pharmaceutical quality control settings. The company serves healthcare providers, laboratories, food industry, and pharmaceutical manufacturers with rapid PCR-based diagnostic solutions.
Founders & leadership
CH
Christopher HibberdNamed on SEC filing
KB
Kenneth BuechlerNamed on SEC filing
PM
Paul McPhersonNamed on SEC filing
Board
JB
James BlairBoard director
JS
James ScopaBoard director
DD
David DouglassBoard director
FD
Frederick DotzlerBoard director
KB
Kim BlickenstaffBoard director
Investors · 3
Kaiser Permanente Ventureslisted by Kaiser Permanente VenturesSan Francisco · $2M – $5M
How we know: Kaiser Permanente Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Moore Venture Partnerslisted by Moore Venture PartnersSan Diego
How we know: Moore Venture Partners's portfolio page · Not right? Tell us
Domain AssociatesreportedPrinceton · $200K – $15M
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$91.1M disclosed across 5 rounds · 2014–2016
▶$43MraisedDec 2016 · 18 investors · OtherRule 506(b)
▶$43MraisedDec 2016 · 18 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Todd MyersExecutive Officer
- David DouglassDirector
- James BlairDirector
- Christopher HibberdExecutive Officer, Director
- Kenneth BuechlerDirector
- James ScopaDirector
- Kim BlickenstaffDirector
- Frederick DotzlerDirector
- Paul McPhersonExecutive Officer, Director
- Offering amount
- $43M
- Amount sold
- $43M
- Sales commissions
- $2M
- Placement agents
- PIPER JAFFRAY & CO.
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedDec 2016 · 17 investors · OtherRule 506(b)
▶$3MraisedDec 2016 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kim BlickenstaffDirector
- Kenneth BuechlerDirector
- Todd MyersExecutive Officer
- James BlairDirector
- Frederick DotzlerDirector
- David DouglassDirector
- Christopher HibberdExecutive Officer, Director
- Paul McPhersonExecutive Officer, Director
- James ScopaDirector
- Amount sold
- $3M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedOct 2015 · 1 investors · OtherRule 506(b)
▶$20MraisedOct 2015 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James BlairDirector
- Todd MyersExecutive Officer
- James ScopaDirector
- Kim BlickenstaffDirector
- Christopher HibberdExecutive Officer, Director
- Kenneth BuechlerDirector
- David DouglassDirector
- Paul McPhersonExecutive Officer, Director
- Frederick DotzlerDirector
- Offering amount
- $28M
- Amount sold
- $20M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.1MraisedJul 2014 · 35 investors · OtherRule 506(b)
▶$20.1MraisedJul 2014 · 35 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Todd MyersExecutive Officer
- Christopher HibberdExecutive Officer, Director
- Kenneth BuechlerDirector
- Paul McPhersonExecutive Officer, Director
- David DouglassDirector
- Frederick DotzlerDirector
- James ScopaDirector
- James BlairDirector
- Kim BlickenstaffDirector
- Offering amount
- $20.1M
- Amount sold
- $20.1M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedMar 2014 · 31 investors · OtherRule 506(b)
▶$5MraisedMar 2014 · 31 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Christopher HibberdExecutive Officer, Director
- Todd MyersExecutive Officer
- Kenneth BuechlerDirector
- Kim BlickenstaffDirector
- Frederick DotzlerDirector
- James ScopaDirector
- Paul McPhersonExecutive Officer, Director
- James BlairDirector
- David DouglassDirector
- Amount sold
- $5M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Astute Medical.
Frequently asked questions
- What does Astute Medical do?
- bioMérieux develops in vitro diagnostic systems and molecular testing panels for pathogen detection in clinical, food safety, and pharmaceutical quality control settings. The company serves healthcare providers, laboratories, food industry, and pharmaceutical manufacturers with rapid PCR-based diagnostic solutions.
- Who are Astute Medical's investors?
- Astute Medical's investors include Kaiser Permanente Ventures, Moore Venture Partners, Domain Associates.
- How much funding has Astute Medical raised?
- Astute Medical has disclosed $91.1M raised across 5 rounds.
- Where is Astute Medical headquartered?
- Astute Medical is headquartered in San Diego, US.